Merck gets USFDA approval for adjuvant Keytruda for pediatric, adult Melanoma Ruchika Sharma5 Dec 2021 9:30 AM ISTKenilworth: Merck, known as MSD outside the United States and Canada, has announced that the U.S. Food and Drug Administration (USFDA) has approved...
Merck Keytruda gets USFDA nod as adjuvant kidney cancer treatment Ruchika Sharma19 Nov 2021 3:56 PM ISTKenilworth: Merck, known as MSD outside the United States and Canada, has recently announced that the U.S. Food and Drug Administration (FDA)...
Gilead Sciences, Merck collaborate to evaluate Trodelvy in combo with Keytruda Ruchika Sharma31 Oct 2021 9:30 AM ISTFoster City: Gilead Sciences, Inc. has recently announced the company has entered into a clinical trial collaboration and supply agreement with Merck...
Merck Keytruda in combination with chemotherapy gets European nod as treatment for breast cancer Ruchika Sharma24 Oct 2021 9:30 AM ISTKenilworth: Merck, known as MSD outside the United States and Canada, has recently announced that the European Commission (EC) has approved KEYTRUDA,...
Reduced GST rates on COVID drugs extended till December Ruchika Sharma18 Sept 2021 5:44 PM ISTLucknow: The GST Council on Friday extended concessional tax rates on COVID-19 medicines, cut tax on cancer drugs and waived GST on import of highly...
Merck Research chief Roger Perlmutter to step down Ruchika Sharma5 Oct 2020 1:30 PM ISTDean Li, who joined Merck's R & D team in 2017, will take over from Perlmutter.
Merck's Keytruda extends survival in lung cancer study Meghna A Singhania27 Oct 2015 11:14 AM ISTMerck & Co's approved Keytruda lung cancer treatment provided superior overall survival to chemotherapy in a late-stage study of patients with...
FDA approves immunotherapy drug to treat lung cancer Pooja Bhatia Bhatia6 Oct 2015 10:55 AM ISTThe US Food and Drug Administration (FDA) has recently approved an immunotherapy drug to treat lung cancer, which includes thee advanced nom-small...
FDA expands Merck drug's approval to treat lung cancer Meghna A Singhania4 Oct 2015 12:35 PM ISTWASHINGTON: Federal health officials have expanded approval of an innovative Merck drug to treat patients with an advanced form of the most common...
